ALB and familial pancreatic carcinoma: Combination therapy with gemcitabine and nanoparticle albumin-bound paclitaxel (nab-paclitaxel), known as GnP therapy, significantly prolongs the survival of pancreatic cancer patients compared with conventional therapies such as gemcitabine monotherapy, and is considered as a standard treatment for pancreatic cancer chemotherapy, together with FOLFIRINOX (combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) [11, 12].